TOKYO -- Takeda Pharmaceutical plans seek approval from U.S. regulators to sell a dengue fever vaccine there, aiming to become the first Japanese company to enter the American vaccine market, Nikkei has learned.
Pharmaceuticals
Japan's Takeda aims to sell vaccines in U.S., targeting dengue first
Drugmaker hopes to break into market dominated by American and European players
A Takeda vaccine factory in Germany. The Japanese drugmaker will apply for approval to sell its dengue vaccine in the U.S. (Takeda Pharmaceutical)
Read Next
Latest on Pharmaceuticals
